Individuals
Businesses
Company
Intelligence
News
African Capital Markets
EnglishEnglish
share on twittershare on linkedinshare on facebookshare to whatsapp
share on mail
share on instagram

Egypt’s Pharmacy Marts secures bridge round from Acasia Ventures

Daba Finance/Egypt’s Pharmacy Marts secures bridge round from Acasia Ventures
STARTUP VENTURE CAPITALMarch 21, 2024 at 9:57 PM UTC

TLDR

  • Acasia Ventures invests six figures in Cairo-based digital marketplace Pharmacy Marts, covering 20% of Egypt's market with 200+ suppliers.
  • Founded in 2021 by Ahmed Kadous, Ahmed Mazhar, Haitham El Ghotni, and Mahmoud Shousha, Pharmacy Marts bridges pharmacies and medical suppliers online.
  • Pharmacy Marts secures a total of $2 million in investments, aiming to enhance patient access to medication through digitalization of the pharmaceutical supply chain.

Acasia Ventures, an early-stage venture capital firm, has injected a six-figure bridge round investment into Cairo-based digital marketplace Pharmacy Marts. The startup asserts coverage of 20% of Egypt's total market and proudly boasts over 200 suppliers on its platform.

Established in 2021 by Ahmed Kadous, Ahmed Mazhar, Haitham El Ghotni, and Mahmoud Shousha, Pharmacy Marts serves as a B2B digital marketplace facilitating the connection between pharmacies and medical suppliers for the seamless procurement of medicine, medical supplies, and cosmetics.

With this recent investment, Pharmacy Marts has raised a total of $2 million in investments to date. The ultimate goal is to digitize the pharmaceutical sector’s supply chain to improve patient access to medication.

Key Takeaways

The market opportunity to serve community pharmacies across Africa is significant; the Middle East and Africa’s pharma market is said to be worth around $100 billion. Like Pharmacy Marts, there is an increasing number of health tech startups that are streamlining the pharmaceutical sector across the continent, serving businesses and individual customers in an industry that has for decades remained fragmented, leading to frequent stock unavailability, quality concerns, and unstable pricing. These include Grinta, Vezeeta, mPharma, Lifestores, and Drugstoc.

Pharmacy Marts
Acasia Ventures
Healthtech
Digital Marketplace
Venture Capital
Egypt
Healthcare

Think someone else should see this?

share on twittershare on linkedinshare on facebookshare to whatsapp
share on mail
share on instagram
Stay informed with our newsletters read by 25,000+ professionals worldwide
Newsletter companiesNewsletter companiesNewsletter companiesNewsletter companiesNewsletter companiesNewsletter companies

Next Frontier

Stay up to date on major news and events in African markets. Delivered weekly.

Pulse54

UDeep-dives into what’s old and new in Africa’s investment landscape. Delivered twice monthly.

Events

Sign up to stay informed about our regular webinars, product launches, and exhibitions.

+25k investors have already subscribed

To invest in this opportunity and other opportunities across Africa

Download the daba finance app on your mobile through
appstore iconappstore icon
Phone Image

Take action.

Download app

Start investing in Africa’s best opportunities, including stocks, bonds, startups, venture funds, and more.

Partner with us

Unlock exciting business opportunities and growth potential.

Join Daba

Become a part of our vibrant community and enjoy exclusive benefits.

Contact us

Reach out to us for inquiries, support, or collaboration.
For Investor
StrategiesPortfolio ManagementAfrican Capital MarketsNews
Daba Pro Intelligence
For Capital Seekers
For StartupsFor Fund ManagersFor Private CompaniesFor Lenders
For Partners
Commercial BanksBroker DealersAsset ManagersInvestment BanksInvestment Advisors and ConsultantsLenders and Microfinance
Company
About UsMarket UpdatesEventsBlog and PodcastNewsletterCase StudiesAffiliate ProgramInvesting GlossaryOfficial ContactsTrust, Compliance and SecurityFrequently Asked Questions

Terms & ConditionsPrivacy Policy
EnglishEnglish

Owned by Daba Markets Inc. By using this site, you accept our Terms and Conditions and Privacy Policy. © 2024 All rights reserved. 2025 All rights reserved